Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies. Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies for rare neurological disorders. The company discovers, develops, and delivers therapies for CNS disorders. Its initial focus is on SCA.
Health Care, Medical, Pharmaceutical
Above €25 million
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as Vico Therapeutics? We’re happy to assist you with our Startup Sourcing service.